BIOCHEMICAL STUDY OF MYELINATION AND DEMYELINATION
BIOCHEMICAL STUDY OF MYELINATION AND DEMYELINATION
批准号:
2264716
负责人:
Robert K. YU
金额:
$20.15万
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-07-01 至 1995-03-31
关键词:
astrocytes autoantigens autoimmune disorder brain metabolism cell adhesion molecules cerebrosides densitometry enzyme linked immunosorbent assay experimental allergic encephalomyelitis galactosyltransferases gangliosides glycolipids glycosphingolipids guinea pigs high performance liquid chromatography laboratory mouse laboratory rabbit laboratory rat lipid biosynthesis lipid structure monoclonal antibody multiple sclerosis myelination nervous system disorder diagnosis neurochemistry nucleic acid probes oligodendroglia radioimmunoassay vascular endothelium permeability
中文摘要
本应用程序的总体目标是研究生物化学和
多发性硬化(MS)脱髓鞘的免疫学基础
实验性变态反应性脑脊髓炎(EAE)及其生化
影响髓鞘形成和再髓鞘形成的参数。我们的重点是
糖鞘糖脂(GSLS)在这些事件中的作用。由于GSLS是
主要定位于细胞表面,已知经历了细胞-
特定的、发育调节的变化,它们是极好的
用于监测髓鞘形成过程中发生的细胞事件的标志物
脱髓鞘。它们在这方面的重要性由以下方面进一步强调:
(A)发现存在独特的糖脂抗原
神经系统和内皮细胞,以及(B)某些GSLS是强大的
免疫细胞生长和分化的调节剂。在…的第一个领域
研究的一个主要目标是提供更多关于髓鞘的生化数据
崩溃,相关的神经胶质反应,以及重新髓鞘形成。这是
由开发的几种新奇和高度敏感的
分析特定蜂窝GSL组件的程序。免疫学
对多发性硬化症的研究一直很广泛,有强有力的证据表明,
自身免疫机制可能在该病的发病机制中起重要作用。
疾病。涉及髓鞘和髓鞘的自身抗原(S)
多发性硬化症少突胶质细胞变性的定义尚不清楚。我们
假设MS和EAE的炎性脱髓鞘可能是
由CNS髓鞘蛋白特异性自身反应性T细胞触发
糖偶联物,并通过对靶抗原的体液反应
特异性地定位于内皮细胞和中枢神经系统。幽默
对内皮的反应可能是血管通透性的原因
改变之前的脱髓鞘。这一假设将通过以下方式进行检验
体外和体内模型系统。在第二个研究领域,我们
计划将重点放在合成高含量的半乳脑苷脂(GC)上
富含髓鞘的。由于GC有两种类型,因此有可能
它们是由两种不同的半乳糖基转移酶合成的。
我们计划提纯这两种酶,并研究它们的亚细胞
定位,并阐明酶活性的调节
在分子生物学技术的发展过程中。自.以来
半乳糖基转移酶明显存在于少突胶质细胞的血浆中
膜和髓鞘,我们认为它们可能起到膜黏附的作用。
形成髓鞘多层结构的分子。一个
了解半乳脑苷脂的合成和功能应
增强我们对调节髓鞘形成和再髓鞘形成的因素的认识。
英文摘要
The overall objective of this application is to study the biochemical and
immunological basis of demyelination in multiple sclerosis (MS) and
experimental allergic encephalomyelitis (EAE), as well as the biochemical
parameters affecting myelination and remyelination. Our emphasis is placed
on the role of glycosphingolipids (GSLs) in these events. Since GSLs are
localized primarily on the cell surface and are known to undergo cell-
specific, developmentally regulated changes, they serve as excellent
markers for monitoring cellular events occurring during myelination and
demyelination. Their importance in this regard is further underscored by:
(a) the discovery that there are unique glycolipid antigens common to the
nervous system and the endothelial cells, and (b) certain GSLs are powerful
modulators of immune cell growth and differentiation. In the first area of
research, a major goal is to provide additional biochemical data on myelin
breakdown, the associated gliotic reactions, and remyelination. This is
facilitated by the development of several novel and highly sensitive
procedures for analyzing specific cellular GSL components. Immunological
research in MS has been extensive, and there is strong evidence that an
autoimmune mechanism may play an important role in the pathogenesis of this
disease. The autoantigen(s) that are involved in myelin and
oligodendroglial degeneration in MS have not been clearly defined. We
hypothesize that the inflammatory demyelination in MS and EAE may be
triggered by autoreactive T cells specific for CNS myelin proteins and
glycoconjugates, and by humoral response against target antigens
specifically localized in endothelial cells and the CNS. The humoral
response against the endothelium may account for the vascular permeability
change preceding demyelination. This hypothesis will be tested employing
in vitro and in vivo model systems. In the second area of research, we
plan to focus on the synthesis of galactocerebrosides (GC) which are highly
enriched in myelin. Since there are two types of GC, the possibility
exists that they are synthesized by two distinct galactosyltransferases.
We plan to purify these two enzymes and to study their subcellular
localization, and to elucidate the regulation of the enzyme activities
during development by molecular biological techniques. Since
galactosyltransferases are apparently found in oligodendroglial plasma
membrane and myelin, we propose that they may function as membrane adhesion
molecules for the formation of the multilamellar structure of myelin. An
understanding of the synthesis and function of galactocerebrosides should
enhance our knowledge on factors modulating myelination and remyelination.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Morphometric analysis of the developing optic nerve of the F1 heterotic mouse and its parental strains.
F1 杂种优势小鼠及其亲本品系发育中视神经的形态测量分析。
DOI:
10.1016/0304-3940(90)90828-w
发表时间:
1990
期刊:
Neuroscience letters
影响因子:
2.5
作者:
[Bigbee,JW, Yu,DS, Yu,RK]
通讯作者:
Yu,RK
Modulation by glycosphingolipids of membrane-membrane interactions induced by myelin basic protein and melittin.
鞘糖脂对髓磷脂碱性蛋白和蜂毒肽诱导的膜-膜相互作用的调节。
DOI:
10.1016/0005-2736(92)90260-s
发表时间:
1992
期刊:
Biochimica et biophysica acta
影响因子:
--
作者:
[Maggio,B, Yu,RK]
通讯作者:
Yu,RK
Heterosis for myelin content is limited to the central nervous system.
髓磷脂含量的杂种优势仅限于中枢神经系统。
DOI:
10.1002/jnr.490190312
发表时间:
1988
期刊:
Journal of neuroscience research
影响因子:
4.2
作者:
[Miskimins,R, Yu,RK]
通讯作者:
Yu,RK
Sulfated glucuronyl glycolipids and gangliosides in the optic nerve of humans.
人类视神经中的硫酸化葡萄糖醛酸糖脂和神经节苷脂。
DOI:
10.1212/wnl.43.2.408
发表时间:
1993
期刊:
Neurology
影响因子:
9.9
作者:
[Yoshino,H, Maeda,Y, King,M, Cartwright,MJ, Richards,DW, Ariga,T, Yu,RK]
通讯作者:
Yu,RK
Fucosyl-GM1 in human sensory nervous tissue is a target antigen in patients with autoimmune neuropathies.
人类感觉神经组织中的岩藻糖基-GM1 是自身免疫性神经病患者的靶抗原。
DOI:
10.1111/j.1471-4159.1993.tb02170.x
发表时间:
1993
期刊:
Journal of neurochemistry
影响因子:
4.7
作者:
[Yoshino,H, Ariga,T, Latov,N, Miyatake,T, Kushi,Y, Kasama,T, Handa,S, Yu,RK]
通讯作者:
Yu,RK
共 6 条
Glycolipids of Neural Stem Cells
-
批准号:9447277
-
项目类别:
-
资助金额:$33.25万
-
财政年份:2017
-
负责人:Robert K. YU
-
依托单位:
Glycolipids of Neural Stem Cells
-
批准号:10062520
-
项目类别:
-
资助金额:$33.25万
-
财政年份:2017
-
负责人:Robert K. YU
-
依托单位:
Effects of Gangliosides on Neural Stem Cells: Role in Neuroregeneration
-
批准号:8598054
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Robert K. YU
-
依托单位:
Effects of Gangliosides on Neural Stem Cells: Role in Neuroregeneration
-
批准号:8413421
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Robert K. YU
-
依托单位:
Effects of Gangliosides on Neural Stem Cells: Role in Neuroregeneration
-
批准号:8240700
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Robert K. YU
-
依托单位:
Neurogenic effects of amyloid beta-proteins and gangliosides in AD
-
批准号:7139266
-
项目类别:
-
资助金额:$12.45万
-
财政年份:2006
-
负责人:Robert K. YU
-
依托单位:
Neurogenic effects of amyloid beta-proteins & gangliosides in Alzheimer's Disease
-
批准号:7282650
-
项目类别:
-
资助金额:$15.17万
-
财政年份:2006
-
负责人:Robert K. YU
-
依托单位:
Neurodegenerative diseases and neural repair
-
批准号:7255765
-
项目类别:
-
资助金额:$18.22万
-
财政年份:2005
-
负责人:Robert K. YU
-
依托单位:
Neurodegenerative diseases and neural repair
-
批准号:7435359
-
项目类别:
-
资助金额:$18.22万
-
财政年份:2005
-
负责人:Robert K. YU
-
依托单位:
Neurodegenerative diseases and neural repair
-
批准号:7643993
-
项目类别:
-
资助金额:$9.98万
-
财政年份:2005
-
负责人:Robert K. YU
-
依托单位:
Neurodegenerative diseases and neural repair
-
批准号:7089075
-
项目类别:
-
资助金额:$18.22万
-
财政年份:2005
-
负责人:Robert K. YU
-
依托单位:
Neurodegenerative diseases and neural repair
-
批准号:6894138
-
项目类别:
-
资助金额:$17.02万
-
财政年份:2005
-
负责人:Robert K. YU
-
依托单位:
American Society for Neurochemistry Conference
-
批准号:6671647
-
项目类别:
-
资助金额:$3.0万
-
财政年份:2003
-
负责人:Robert K. YU
-
依托单位:
MOLECULAR STUDY ON MYELIN-ASSOCIATED NEURAMINIDASE
-
批准号:2332955
-
项目类别:
-
资助金额:$16.45万
-
财政年份:1995
-
负责人:Robert K. YU
-
依托单位:
MOLECULAR STUDY ON MYELIN-ASSOCIATED NEURAMINIDASE
-
批准号:2266617
-
项目类别:
-
资助金额:$15.87万
-
财政年份:1995
-
负责人:Robert K. YU
-
依托单位:
GLYCOLIPIDS AND EXPERIMENTAL NEUROPATHY
-
批准号:6187215
-
项目类别:
-
资助金额:$27.35万
-
财政年份:1988
-
负责人:Robert K. YU
-
依托单位:
GLYCOLIPIDS AND EXPERIMENTAL NEUROPATHY
-
批准号:2714473
-
项目类别:
-
资助金额:$25.3万
-
财政年份:1988
-
负责人:Robert K. YU
-
依托单位:
GLYCOLIPIDS AND EXPERIMENTAL NEUROPATHOLOGY
-
批准号:2266228
-
项目类别:
-
资助金额:$27.45万
-
财政年份:1988
-
负责人:Robert K. YU
-
依托单位:
GLYCOLIPIDS AND EXPERIMENTAL NEUROPATHY
-
批准号:2266229
-
项目类别:
-
资助金额:$24.7万
-
财政年份:1988
-
负责人:Robert K. YU
-
依托单位:
SPHINGOGLYCOLIPIDS IN NORMAL AND PATHOLOGICAL BRAINS
-
批准号:3394618
-
项目类别:
-
资助金额:$25.14万
-
财政年份:1988
-
负责人:Robert K. YU
-
依托单位:
海外基金